Radial acquires TMS Health Partners, MSO behind network of brain medicine clinics

Radial, an MSO focused on brain medicine clinics, has acquired TMS Health Partners, the non-clinical assets of Mindful Health Solutions. The acquisition expands Radial's total clinic count to 27 across 7 states, offering advanced brain medicine treatments such as rapid-acting medications and neuromodulation. Radial's CEO, John Capecelatro, emphasizes that brain medicine is a new discipline primarily in an academic setting, and they are among the first to bring this category to outpatient settings.

Their clinics manage conditions like PTSD, OCD, treatment-resistant depression, and suicidality, providing treatments such as transcranial magnetic stimulation (TMS), Spravato, and ketamine infusion therapy. Radial, backed by General Catalyst, supports these clinics by facilitating the purchase of expensive medications and devices, managing billing, and guiding providers through an AI clinical decision support tool called RadialOS.

Although TMS and Spravato are not cures, they have shown significant effectiveness, with about half of individuals with depression experiencing a clinically meaningful response. Radial's clinical network has contributed to numerous peer-reviewed studies and collaborates with companies like Compass Pathways, which is developing synthetic psilocybin for treatment-resistant depression and PTSD.

Radial aims to enhance awareness of brain medicine treatments, streamline the patient care journey, and support research into broader neurological and neurodegenerative conditions.